Lung Cancer

Latest News

Graphic that resembles a stamp of approval reading "FDA Approved"
Taletrectinib Approved by FDA for ROS1+ Non-Small Cell Lung Cancer

June 11th 2025

The tyrosine kinase inhibitor taletrectinib has been approved for use in patients with ROS1-positive non-small cell lung cancer.

Graphic of lungs with tumors
Chemo With Molecular Guidance Improves Survival in Early NSCLC

June 5th 2025

Anatomical graphic of a person with a tumor in their left lung
Tarlatamab Supported as Second-Line SOC by DeLLphi-304 in SCLC

June 4th 2025

Photo of a person in a lab coat inspecting the arm of a woman
Dermatologic Protocol Preserves QOL in EGFR+ Advanced NSCLC Treatment

June 4th 2025

Line illustration of lungs with a tumor in the left lung
Sevabertinib Given FDA Priority Review for HER2+ NSCLC

May 29th 2025

Latest CME Events & Activities

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Go To PER in Chicago

May 30, 2025 - June 3, 2025

Register Now!

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies

View More

Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care

View More

Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

View More

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

View More

19th Annual New York GU Cancers Congress™

March 13-14, 2026

Register Now!

Medical Crossfire®: Expert Interpretations of the Latest Data in CLL Management – Understanding the Impact of Optimal Treatment Selection on Patient Outcomes

View More

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

View More